Editorial

Journal of Atherosclerosis and Thrombosis

Volumn 11, Issue 2, 2004, Pages 101-103

  Saito, Yasushi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING CESSATION; DISEASE MANAGEMENT; PATIENT CARE; PRACTICE GUIDELINE; STANDARDS; ARTERIOSCLEROSIS; JAPAN; SMOKING;

ATHEROSCLEROSIS; DISEASE MANAGEMENT; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC; ARTERIOSCLEROSIS; DIABETES MELLITUS; JAPAN; PRACTICE GUIDELINES; SMOKING;

EID: 10944232243     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/JAT.11.101     Document Type: Editorial

References (13)

1. Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias: Report of the Japan Atherosclerosis Society (JAS) guideline for the diagnosis and treatment of hyperlipidemia in Japanese adults. J Atheroscler Thromb, 9: 1-27, 2002
2. Stamler J, Wentworth D, and Neaton JD: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple. Risk Factor Intervention Trial (MRFIT). JAMA, 256: 2823-2828, 1986.
3. Nakamura Y, Yamaoka O, Uchida K, Morigami N, Sugimoto Y, Fujita T, Inoue T, Fuchi T, Hachisuka M, Ueshima H, Shimakawa H, and Kinoshita M: Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: Results of SHIPS (SHIga Pravastatin Study). Cardiovasc Drugs Ther, 10: 475-483, 1996
4. Sugimoto K, Chikamori T, Kitaoka H, Furuno T, Seo H, Takata J, Yonezawa Y, and Doi Y: Efficacy of cholesterol lowering therapy on the prognosis of Japanese patients with coronary artery disease. J Noninvas Cardiol, 3: 86-90, 1999
5. Chikamori T, Sugimoto K, Hamada T, Kitaoka H, Furuno T, Seo H, and Doi Y: Efficacy of cholesterol- lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol levei using 3-hydroxy-3-methylglutaryl coenzyme A re- ductase inhibitor. J Cardiol, 35: 95-101, 2000
6. Koizumi J, Shimizu M, Miyamoto S, Origasa H, and Mabuchi H: Effect of pravastatin-induced LDL-cho- lesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial (Holicos-PAT). J Atheroscler Thromb, 9: 251-259, 2002
7. The Kyushu Lipid Intervention Study Group: Pravastatin use and risk of coronary events and cerebral infarction in Japanese men with moderate hypercholesterolemia: The Kyushu Lipid Intervention Study. J Atheroscler Thromb, 7:110-121, 2000
8. Ito H, Ouchi Y, Ohashi Y, Saito Y, Ishikawa T, Nakamura H, and Orimo H: A comparison of low versus Standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: The pravastatin anti-atherosclerosis trial in the elderly (PATE). J Atheroscler Thromb, 8: 33-44, 2001
9. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and J-LIT Study Group: Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J, 66:1087-1095, 2002
10. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and J-LIT Study Group: Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin Editorialtherapy in Japanese patients with hypercholesterolemia and coronary heart disease: Secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 66:1096-1100, 2002
11. Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and J-LIT Study Group: Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J, 67:287-294, 2003
12. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, and Cohen JD: Serum cholesterol leveis and six-year mortality from stroke in 350, 977 men screened for the multiple risk factor intervention trial. N Engl J Med, 320: 904-910, 1989
13. Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, and Ross W: Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke, 25: 814-820, 1994